AQILION AB
PrivateLast Round
VC Round
Apr 2, 2025
Est. Valuation
$9.23M
Company Overview
AQILION AB is a biotechnology company that develops innovative treatments for diseases caused by chronic inflammation and dysfunctional immune reactions, such as autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AQILION AB Comparables
Compare AQILION AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Knopp Biosciences | 80% | |
| Redoxis AB | 77% | |
| Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. | 76% | |
AQILION AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 2, 2025 | ||||
| VC Round | Sep 7, 2022 | ||||
| Strategic | Dec 3, 2021 |
AQILION AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AB Grenspecialisten | VC Round |
| Fåhraeus Startup and Growth | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Monthly visitors increased 92% MoM.
- Jan 28, 2025
Monthly visitors increased 248% MoM.
AQILION AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AQILION AB's valuation, stock price, and market status.